EFFECT OF AQUEOUS EXTRACT OF CRYPTOLEPIS SANGUINOLENTA ON PHARMACOKINETICS OF ARTESUNATE

Authors

  • Sakyiamah M M Department of Biochemistry, Cell and Molecular Biology, Faculty of Science, P. O. Box LG4, University of Ghana, Legon-Accra, Ghana
  • Ocloo A Department of Biochemistry, Cell and Molecular Biology, Faculty of Science, P. O. Box LG4, University of Ghana, Legon-Accra, Ghana
  • Adjimani J P Department of Biochemistry, Cell and Molecular Biology, Faculty of Science, P. O. Box LG4, University of Ghana, Legon-Accra, Ghana
  • Sittie A Centre for Scientific Research into Plant Medicine, P. O. Box 73, Mampong-Akuapeng, Ghana

Abstract

The aim of this study is to investigate the effect of aqueous extract of Cryptolepis sanguinolenta on the pharmacokinetics of the antimalarial; artesumate in male Sprague-Dawley rats. Reconstituted freeze dried Cryptolepis sanguinolenta was administered in drinking water at the therapeutic dose of 36 g/kg body weight for two (2) weeks, followed by a single oral dose of artesunate (150 mg/kg body weight). The Concentration - Time course; Maximum Whole Blood Concentration, Cmax; Time for the Maximum Concentration, Tmax; Bioavailability; Elimination Rate Constant; Half- life; Clearance; Volume of Distribution and Absorption Rate Constant were measured. Results indicated that about 80% of dihydroartemisinin was recovered during extraction suggesting that the extraction procedure was effective. The elimination rate constant and clearance of dihydroartemisinin the most potent metabolite of artesunate increased by 233.3% and 62.1% respectively in rats which received concurrent administration of Cryptolepis sanguinolenta compared to control (artesunate only). This resulted in significant decrease (p < 0.05) in the Bioavailability (40.1%), Volume of Distribution (68.1%) and Half-life (52.1%) of dihydroartemesinin. The findings therefore, showed that Cryptolepis sanguinolenta could cause sub-therapeutic blood levels of dihydroartemisinin of artesunate leading to decreased effectiveness and possibly drug resistance as a result of herb-drug interactions. Thus, in clinical practice, patients should be advised on the serious implication of using Cryptolepis sanguinolenta and artesunate together.

Keywords:

Cryptolepis sanguinolenta, Pharmacokinetics, Artesunate, herb-drug interaction.

DOI

https://doi.org/10.25004/IJPSDR.2011.030408

References

1. Delgodaa R, Youngerb N, Barretc C, Braithwaitec J, Davisc D. The prevalence of herbs use in conjunction with conventional medicines in Jamaica. Complementary therapies in Medicine 2011; 18(1):13-20.
2. Chen J. Recognition and Prevention of Herb-Drug Interactions: Pharmacokinetic Interactions. Acupuncture Today 2006; 7(11).
3. Foster S. Treatment of malaria outside the formal health services. J Trop Med Hyg.1995; 98:29-34.
4. Ruebush TK, Kern MK, Campbell CC, Oloo AJ. Self treatment of malaria in a rural area of Western Kenya. Bull World Health Organ. 1995; 73: 229-236.
5. Wernsdorfer WH. The development and Spread of drug – resistant malaria Parasitol. Today 1991; 7: 297-303.
6. Rathod PK, McErlean T, Pei-Chieh C. Variations in frequencies of drug resistance in Plasmodium falciparium. Proc. Natl. Acad. Sci.1997; 94:9389-93.
7. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002; 415: 673-679.
8. Ali BH, Al-Qarawi A, Mousa HM. Effect of grapefruit juice on plasma chloroquine kinetics in mice. Clin. and Exp. Pharmacol. and Physio. 2002; 29: 704-706.
9. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Fallon J. Indinavir concentrations and St. John’s wort. Lancet 2000; 355: 547-548.
10. Okonta JM, Uboh M, Obonga WO. Herb-Drug Interaction: A Case Study of Effect of Ginger on the Pharmacokinetic of Metronidazole in Rabbit. Indian J Pharm Sci. 2008; 70(2): 230-232.
11. Ang-Lee M, Moss J, Yuan CS. Herbal medicines and perioperative care JAMA 2001; 286:208-216.
12. Roger T. Herb-Drug Interaction. CATIE Factsheets, 2004; 1-6.
13. Clement YN, Williams AF, Khan K, Bernard T, Bhola S, Fortune M, Medupe O, Nagee K., Seaforth CE. A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complement Altern Med. 2005; 18: 20.
14. Matthews SC, Camacho A, Lawson K, Dimsdale JE. Use of herbal medications among 200 psychiatric outpatients: prevalence, patterns of use, and potential dangers. Gen Hosp Psychiatry 2003; 25: 24-6.
15. Ortelli D, Ructaz S, Cognarct E, Veuthe JL. Analysis of Dihydroartemisinin in Plasma by Liquid Chromatography-Mass Spectrometry. Chromatographia, 2000; 52 (7/8):445-450.
16. Shargel L, Yu ABC. Applied Biopharmaceutics and Pharmacokinetics, 3rd ed., Appleton and Lange, Stamford, CT, 1993, pp108-109, 154-163.
17. Rath K, Taxis K, Walz G, Gleiter CH, Li SM, Heide L. Pharmakokinetic study of artemisinin after oral intake of a traditional preparation of Artemisinin annua L. (annual wormwood). Am. J Trop Med Hyg. 2004; 70(2):128-32.
18. Lazarou L, Pomeranz B, Corey PN. Incidence of adverse interactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200 – 1205.
19. Jacubeit T, Drisch D, Weber E. Risk factors as reflected by an intensive drug monitoring system. Agents Actions 1990; 29: 117- 25.
20. Nwafor SV, Akah PA, Okoli CO, Onyirioha AC. Nworu CS. Interaction between chloroquine sulphate and aqueous extract of Azadirachta indica A. Juss (Meliaceae) in rabbits. Acta Pharm. 2003; 53: 305-311.
21. Batty KT, Thu LTA, Davis TME. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 1998; 45: 123 - 129.
22. Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet. 2000; 39 (4); 255-70.
23. Thomson A. Back to basics: Pharmacokinetics. J. Pharmaceu. 2004; 272:769 – 808.
24. Svensson USH, Ashton M. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol. 1998, submitted.
25. Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV, Petzold, MG, Simonsson US, Ashton M. Artemisinin antimalarials moderately affect Cytochrome P450 enzyme activity in healthy subjects. Fundam Clin Pharmacol. 2007; 21(3):307-16.

Published

01-10-2018
Statistics
Abstract Display: 280
PDF Downloads: 362
Dimension Badge

How to Cite

“EFFECT OF AQUEOUS EXTRACT OF CRYPTOLEPIS SANGUINOLENTA ON PHARMACOKINETICS OF ARTESUNATE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 3, no. 4, Oct. 2018, pp. 313-8, https://doi.org/10.25004/IJPSDR.2011.030408.

Issue

Volume 3, Issue 4, 2011

Section

Research Article

How to Cite

“EFFECT OF AQUEOUS EXTRACT OF CRYPTOLEPIS SANGUINOLENTA ON PHARMACOKINETICS OF ARTESUNATE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 3, no. 4, Oct. 2018, pp. 313-8, https://doi.org/10.25004/IJPSDR.2011.030408.